First Trust Direct Indexing’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-5,446
Closed -$1.33M 718
2024
Q3
$1.33M Buy
5,446
+568
+12% +$127K 0.07% 278
2024
Q2
$934K Buy
4,878
+588
+14% +$119K 0.06% 326
2024
Q1
$850K Buy
4,290
+505
+13% +$92.5K 0.06% 334
2023
Q4
$651K Buy
3,785
+738
+24% +$113K 0.06% 372
2023
Q3
$451K Sell
3,047
-299
-9% -$54.1K 0.05% 422
2023
Q2
$731K Buy
3,346
+65
+2% +$14.5K 0.08% 296
2023
Q1
$719K Sell
3,281
-65
-2% -$14.1K 0.09% 296
2022
Q4
$696K Sell
3,346
-683
-17% -$150K 0.09% 287
2022
Q3
$880K Buy
4,029
+587
+17% +$134K 0.13% 212
2022
Q2
$722K Buy
3,442
+510
+17% +$109K 0.1% 266
2022
Q1
$711K Buy
2,932
+206
+8% +$49.8K 0.09% 293
2021
Q4
$710K Buy
2,726
+90
+3% +$23.4K 0.09% 274
2021
Q3
$695K Sell
2,636
-183
-6% -$50K 0.1% 263
2021
Q2
$695K Buy
2,819
+1,378
+96% +$290K 0.1% 256
2021
Q1
$280K Sell
1,441
-86
-6% -$17.2K 0.07% 321
2020
Q4
$325K Buy
+1,527
New +$304K 0.09% 278

Other funds holding RMD

First Trust Direct Indexing's RMD Position: Q4 2024 in Review

First Trust Direct Indexing sold out of ResMed (RMD) in Q4 2024, closing a stake of 5,446 shares — an estimated $1.33M sold.

First Trust Direct Indexing first reported a position in RMD in Q4 2020 and held it in 16 quarters. The position peaked at $1.33M in Q3 2024. 871 funds tracked by Wall St. Rank hold RMD as of Q4 2024.

  • First Trust Direct Indexing reported no remaining ResMed position as of Q4 2024 after selling out during the quarter.
  • First Trust Direct Indexing sold 5,446 ResMed shares in Q4 2024, an estimated $1.33M.
  • First Trust Direct Indexing first reported a position in ResMed in Q4 2020 and held it in 16 quarters.
  • First Trust Direct Indexing's ResMed position peaked at $1.33M in Q3 2024.
  • 871 funds tracked by Wall St. Rank held ResMed as of Q4 2024.

Based on First Trust Direct Indexing's 13F filing for Q4 2024.